DBV Technologies SA

Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024

04 يونيو 2024 16:30:00 بحسب Nasdaq GlobeNewswire

DBV Technologies Announces Plan to Implement ADS Ratio Change

31 مايو 2024 09:51:12 بحسب Nasdaq GlobeNewswire

DBV Technologies to Participate in Upcoming EAACI 2024 Congress

30 مايو 2024 16:30:00 بحسب Nasdaq GlobeNewswire

DBV Technologies Announces Plan to Implement ADS Ratio Change

17 مايو 2024 16:30:00 بحسب Nasdaq GlobeNewswire

DBV Technologies Announces Results of its 2024 Combined General Meeting

16 مايو 2024 16:30:00 بحسب Nasdaq GlobeNewswire

DBV Technologies to Participate in Upcoming Investor Conferences

09 مايو 2024 16:30:00 بحسب Nasdaq GlobeNewswire

DBV Technologies Reports First Quarter 2024 Financial Results and Business Update

07 مايو 2024 16:30:00 بحسب Nasdaq GlobeNewswire

Combined General Meeting of May 16, 2024

25 أبريل 2024 16:30:00 بحسب Nasdaq GlobeNewswire

Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024

04 أبريل 2024 16:43:40 بحسب Nasdaq GlobeNewswire

DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document

08 مارس 2024 09:33:25 بحسب Nasdaq GlobeNewswire

DBV Technologies Reports Full Year 2023 Financial Results and Business Update

07 مارس 2024 16:30:00 بحسب Nasdaq GlobeNewswire

DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024

04 مارس 2024 16:30:00 بحسب Nasdaq GlobeNewswire

DBV Technologies to Participate in Upcoming AAAAI 2024 Congress

20 فبراير 2024 16:30:00 بحسب Nasdaq GlobeNewswire

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

16 يناير 2024 16:30:00 بحسب Nasdaq GlobeNewswire

Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023  

04 ديسمبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire

DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers

09 نوفمبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023

06 نوفمبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire

DBV Technologies to Present New Data at ACAAI 2023

02 نوفمبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire

DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results

31 أكتوبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire

DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update

27 أكتوبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire